Renaissance Technologies’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $924K | Sell |
99,372
-16,628
| -14% | -$155K | ﹤0.01% | 2558 |
|
2025
Q1 | $781K | Sell |
116,000
-200,000
| -63% | -$1.35M | ﹤0.01% | 2550 |
|
2024
Q4 | $3.36M | Buy |
316,000
+304,700
| +2,696% | +$3.24M | 0.01% | 1702 |
|
2024
Q3 | $165K | Sell |
11,300
-82,000
| -88% | -$1.2M | ﹤0.01% | 3160 |
|
2024
Q2 | $1.13M | Buy |
93,300
+47,782
| +105% | +$578K | ﹤0.01% | 2256 |
|
2024
Q1 | $1.12M | Sell |
45,518
-75,982
| -63% | -$1.87M | ﹤0.01% | 2415 |
|
2023
Q4 | $1.3M | Buy |
121,500
+89,100
| +275% | +$953K | ﹤0.01% | 2228 |
|
2023
Q3 | $271K | Sell |
32,400
-12,100
| -27% | -$101K | ﹤0.01% | 2982 |
|
2023
Q2 | $352K | Buy |
44,500
+15,600
| +54% | +$123K | ﹤0.01% | 3059 |
|
2023
Q1 | $144K | Buy |
28,900
+7,800
| +37% | +$38.9K | ﹤0.01% | 3383 |
|
2022
Q4 | $47K | Sell |
21,100
-400
| -2% | -$891 | ﹤0.01% | 3808 |
|
2022
Q3 | $95K | Hold |
21,500
| – | – | ﹤0.01% | 3613 |
|
2022
Q2 | $69K | Buy |
21,500
+7,500
| +54% | +$24.1K | ﹤0.01% | 3936 |
|
2022
Q1 | $80K | Buy |
+14,000
| New | +$80K | ﹤0.01% | 3829 |
|
2021
Q3 | – | Sell |
-20,400
| Closed | -$353K | – | 3637 |
|
2021
Q2 | $353K | Buy |
+20,400
| New | +$353K | ﹤0.01% | 3089 |
|